Zeniquin 100 mg Tablet is a Health Canada–registered veterinary drug (DIN 02241413) held by Zoetis Canada Inc, containing Marbofloxacin. Health Canada lists its status as Marketed (status date 27 May 2016). Nexara Health has matched 61 registrations of Marbofloxacin across 6 other regulated markets, 2 of them in the same strength and dosage form.

Health Canada registration

Marbofloxacin registered in other markets

61 registrations of the same molecule in 6 national registries outside Canada (first 38 shown, exact strength and form first). Each row is taken from the regulator's own published list; status is shown as the registry reports it.

See every manufacturer of Marbofloxacin worldwide →

Marketed Canadian products with the same active ingredient

Sourcing through Nexara Health

Nexara Health is a Health Canada–licensed wholesaler (DEL #3-002896) in Winnipeg. Because this DIN is marketed in Canada, supply normally comes through the Canadian channel; where the Canadian presentation is short or discontinued, the registrations above show which regulated markets hold an equivalent that can be imported under the Special Access Programme or for clinical comparator use. Request a quote or read how named-patient and foreign-pack supply works in Canada.

Frequently asked questions

Is Zeniquin (DIN 02241413) marketed in Canada?

Yes. Health Canada lists DIN 02241413 as Marketed as of 27 May 2016.

Who holds the Canadian licence for this product?

Zoetis Canada Inc is the company of record in the Health Canada Drug Product Database.

Is Marbofloxacin registered outside Canada?

Yes — Nexara Health has matched 61 registrations in 6 other markets, including 2 in the same strength and dosage form (see the table above).

Where does this data come from?

Health Canada Drug Product Database (DPD), DIN 02241413, status date 2016-05-27; national medicine registries: DH Drug Office, FDA NDC, Fimea Perusrekisteri, Laegemiddelstyrelsen, NPRA, URPL RPL. Nexara Health re-checks these sources weekly and shows the last verification date at the top of the page.

Source: Health Canada Drug Product Database (DPD), DIN 02241413, status date 2016-05-27; national medicine registries: DH Drug Office, FDA NDC, Fimea Perusrekisteri, Laegemiddelstyrelsen, NPRA, URPL RPL.

Health Canada Drug Product Database (DPD), DIN 02241413, status date 2016-05-27; national medicine registries: DH Drug Office, FDA NDC, Fimea Perusrekisteri, Laegemiddelstyrelsen, NPRA, URPL RPL. Last reviewed 2026-09-16. Nexara Health is a licensed wholesaler and supplies licensed entities only; consumer orders are routed to a partner pharmacy.